Streetbeat News

Equity Actions

LMT

Sintavia, an additive designer and manufacturer of advanced thermodynamic components for aerospace & defense applications, has received a direct equity investment from Lockheed Martin Corporation (NYSE:LMT). The terms of the investment were not disclosed. The investment will support the continued development of Sintavia's proprietary thermodynamic designs and components. Sintavia and Lockheed Martin have a longstanding collaboration to expand the research of metal additive manufacturing opportunities.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:19 pm

AREB

American Rebel Holdings has priced its private placement at a combined effective purchase price of $4.37 per unit.

Portfolio Pulse from Bill Haddad

June 28, 2023 | 12:17 pm

BMY

K36 Therapeutics has raised $70M in a Series B financing round to fund clinical proof of concept of KTX-1001, a first-in-class inhibitor of MMSET for treatment of multiple myeloma patients with genetic translocation (4;14). The round was led by Nextech Invest, with participation from Bristol Myers Squibb Company (NYSE:BMY) and other undisclosed investors. The funds will support the ongoing Phase 1 study of KTX-1001 and its expansion into additional hematological and solid tumor indications.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:14 pm

SONN

Sonnet BioTherapeutics has announced a registered direct offering of 5 million shares at $0.45/share, totaling $2.25 million. Following the announcement, the company's shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:14 pm

TSLA

Tesla Inc (NASDAQ:TSLA) marks its 13th anniversary as a publicly traded stock. A $1,000 investment in Tesla during its IPO would have transformed into approximately $157,365 today, representing a return of 15,637% over a 13-year investment period. Bullish predictions for the stock's future include Ark Investment Management's forecast of the stock reaching $2,000 by 2027, and Baron Capital's projection of a price of $500 by 2025.

Portfolio Pulse from Shanthi Rexaline

June 28, 2023 | 12:10 pm

SONN

Sonnet BioTherapeutics has announced a registered direct offering of 5 million shares at $0.45 per share, raising $2.25 million in total.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:07 pm

ASTS

IMBI

NCMI

RIDE

TOVX

Several stocks are experiencing significant pre-market movements. Theriva Biologics (TOVX) surged 76.4% after receiving Orphan Drug Designation from the FDA for a pancreatic cancer treatment. iMedia Brands (IMBI) gained 55.1% following a second Nasdaq non-compliance notice. National CineMedia (NCMI) rose 12.8% after its reorganization plan was confirmed by the US Bankruptcy Court. Biodexa Pharmaceuticals (BDRX) rose 12.5% after announcing a share ratio change. On the downside, AST SpaceMobile (ASTS) fell 22.6% after pricing an upsized offering of Class A common stock, and Lordstown Motors (RIDE) fell 13.1% after filing for Chapter 11 bankruptcy protection.

Portfolio Pulse from Lisa Levin

June 28, 2023 | 12:04 pm

MRAI

Healthtech company Marpai has announced a 1-for-4 reverse stock split, which will be effective from June 29. This move is typically aimed at increasing the market price of shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:04 pm

AXSM

Axsome Therapeutics has announced a proposed public offering of common stock, leading to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:49 am

BYDDF

LI

NIO

TSLA

XPEV

DigiTimes reports that the recovery of the Chinese auto market is expected to be insignificant in June. The report may mention US-listed companies BYD Co Ltd (BYDDF), Li Auto Inc. (LI), NIO Inc. (NIO), Tesla Inc. (TSLA), and XPeng Inc. (XPEV).

Portfolio Pulse from Charles Gross

June 28, 2023 | 11:48 am